Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids (Englisch)
- Neue Suche nach: Arakkal, Alan T.
- Neue Suche nach: Polgreen, Linnea A.
- Neue Suche nach: Chapman, Cole G.
- Neue Suche nach: Simmering, Jacob E.
- Neue Suche nach: Cavanaugh, Joseph E.
- Neue Suche nach: Polgreen, Philip M.
- Neue Suche nach: Miller, Aaron C.
- Neue Suche nach: Arakkal, Alan T.
- Neue Suche nach: Polgreen, Linnea A.
- Neue Suche nach: Chapman, Cole G.
- Neue Suche nach: Simmering, Jacob E.
- Neue Suche nach: Cavanaugh, Joseph E.
- Neue Suche nach: Polgreen, Philip M.
- Neue Suche nach: Miller, Aaron C.
In:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
;
44
, 2
;
110-121
;
2024
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids
-
Beteiligte:Arakkal, Alan T. ( Autor:in ) / Polgreen, Linnea A. ( Autor:in ) / Chapman, Cole G. ( Autor:in ) / Simmering, Jacob E. ( Autor:in ) / Cavanaugh, Joseph E. ( Autor:in ) / Polgreen, Philip M. ( Autor:in ) / Miller, Aaron C. ( Autor:in )
-
Erschienen in:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy ; 44, 2 ; 110-121
-
Verlag:
-
Erscheinungsdatum:01.02.2024
-
Format / Umfang:12 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 44, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 107
-
Issue Information| 2024
- 110
-
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioidsArakkal, Alan T. / Polgreen, Linnea A. / Chapman, Cole G. / Simmering, Jacob E. / Cavanaugh, Joseph E. / Polgreen, Philip M. / Miller, Aaron C. et al. | 2024
- 122
-
Comparison of different sustained‐release opioids and acute respiratory conditions in patients with cancer and chronic kidney diseaseMitsuboshi, Satoru / Imai, Shungo / Kizaki, Hayato / Hori, Satoko et al. | 2024
- 131
-
Efficacy and safety of factor Xa inhibitors in low body weight patientsTan, Yingcong / Hubbard, Cynthia / Owens, Holly / Pitt, James / Giuliano, Christopher / Haan, Bradley / Breeden, Thomas / Sirbu, Dumitru / Pena, Kelsey / Haddox, Trevlyn et al. | 2024
- 141
-
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institutionPrice, Lily / Garrity, Lisa / Stiehl, Sarah et al. | 2024
- 149
-
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase producing Enterobacterales (ESBL‐E)Namiki, Takaya / Yokoyama, Yuta / Hashi, Hideki / Oda, Rentaro / Jibiki, Aya / Kawazoe, Hitoshi / Matsumoto, Kazuaki / Suzuki, Sayo / Nakamura, Tomonori et al. | 2024
- 163
-
Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycinSpyhalsky, Autumn M. / Kim, Se Jin / Meaney, Calvin J. / Smith, Nicholas M. / Shah, Dhaval K. / Hassinger, Amanda B. / Fusco, Nicholas M. et al. | 2024
- 171
-
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effectZou, Shupeng / Ouyang, Mengling / Cheng, Qian / Shi, Xuan / Sun, Minghui et al. | 2024
- 184
-
Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disordersLeppien, Emily E. / Pauling, Erin E. / Smith, Eric / Wisniewski, Brady / Carpenter, Abigayle / Schwier, Nicholas C. et al. | 2024
- 197
-
Methenamine for urinary tract infection prophylaxis: A systematic reviewLi, Jian Mei / Cosler, Leon E. / Harausz, Elizabeth P. / Myers, Courtney E. / Kufel, Wesley D. et al. | 2024
- 207
-
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”Espinoza Cobeñas, Carlos Augusto et al. | 2024
- 208
-
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”Hong, Lisa T. / Downes, Kevin J. / FakhriRavari, Alireza / Abdul‐Mutakabbir, Jacinda C. / Kuti, Joseph L. / Jorgensen, Sarah / Young, David C. / Alshaer, Mohammad H. / Bassetti, Matteo / Bonomo, Robert A. et al. | 2024